China Pharma Holdings (CPHI) Beginning Cash Balance (2013 - 2017)
China Pharma Holdings' (CPHI) quarterly Beginning Cash Balance came in at $2.7 million in Q1 2017, down 57.34% on a YoY basis from $6.2 million in Q1 2016, and down 57.34% quarter-over-quarter from $6.2 million in Q1 2016.
Analysis
China Pharma Holdings (CPHI) Beginning Cash Balance (2013 - 2017) Analysis & Trends
China Pharma Holdings (CPHI) has reported Beginning Cash Balance for 5 consecutive years, with $2.7 million the latest figure, recorded in Q1 2017.
- For the quarter ending Q1 2017, Beginning Cash Balance fell 57.34% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2017 stood at $2.7 million (down 57.34% YoY), and the FY2016 full-year result was $6.2 million, up 17.99% from the prior year.
- Beginning Cash Balance retreated to $2.7 million in Q1 2017 per CPHI's latest filing, from $6.2 million in the prior quarter.
- Across five years, Beginning Cash Balance topped out at $6.2 million in Q1 2016 and bottomed at -$578538.0 in Q2 2013.
- Historically, Beginning Cash Balance has averaged $3.0 million across 5 years, with a median of $3.6 million in 2013.
- The sharpest annual moves came in 2014 and 2017: Beginning Cash Balance jumped 30.05% in 2014, then sank 57.34% in 2017.
- Over 5 years, Beginning Cash Balance stood at -$578538.0 in 2013, then surged by 1135.91% to $6.0 million in 2014, then tumbled by 100.4% to -$24200.0 in 2015, then jumped by 25921.32% to $6.2 million in 2016, then tumbled by 57.34% to $2.7 million in 2017.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $2.7 million, $6.2 million, and -$24200.0 for Q1 2017, Q1 2016, and Q4 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 2.67 Mn |
| Mar 31, 2016 | 6.25 Mn |
| Dec 31, 2015 | -24,200.00 |
| Jun 30, 2015 | 24,200.00 |
| Mar 31, 2015 | 5.30 Mn |
| Mar 31, 2014 | 5.99 Mn |
| Jun 30, 2013 | -578,538.00 |
| Mar 31, 2013 | 4.61 Mn |